GLP-1 and metabolic treatments prescribed after a proper clinical assessment — not a form-fill. Reviewed by a GPhC-registered prescriber, delivered discreetly.
What's included
A GPhC-registered prescriber reviews your health questionnaire before any treatment is issued.
Treatment is dispatched in plain, tracked packaging straight to your door.
Message our clinical team with questions throughout your treatment journey.
GPhC Registered Pharmacy #9010611 — every prescription is clinically reviewed.
You're assessed for a condition, not a specific medicine — our prescriber selects the treatment that's clinically appropriate for you.
Injectable — once weekly
Tirzepatide activates both GIP and GLP-1 receptors simultaneously.
Injectable — once weekly
Semaglutide is a GLP-1 analogue with 94% homology to human GLP-1.
Oral tablet — once daily
Oral semaglutide 25mg uses an absorption enhancer (SNAC) that transiently increases local gastric pH, protecting the semaglutide peptide from enzymatic degradation and enabling transcellular absorption through the gastric mucosa.
Injectable — once daily
Liraglutide is a GLP-1 receptor agonist with 97% homology to human GLP-1.
Oral capsule — 3× daily with meals
Orlistat irreversibly inhibits gastric and pancreatic lipases in the gut lumen, preventing breakdown and absorption of approximately 30% of dietary fat.
Oral tablet — once daily
Orforglipron is a first-in-class oral, non-peptide small-molecule GLP-1 receptor agonist.
Individual results vary. Treatment is prescribed only if clinically appropriate following assessment by a GPhC-registered prescriber.
Step 1
A short health questionnaire covering your weight history, health conditions and goals.
Step 2
A GPhC-registered prescriber reviews your answers and confirms the right treatment for you.
Step 3
Your treatment is dispatched straight to your door, with ongoing support from our team.
We use essential cookies to run our site, and — with your consent — analytics cookies to understand how it's used. See our Cookie Policy.